Status:
COMPLETED
An Observational Study of Blood Management Techniques in Oncology Surgical Treatment
Lead Sponsor:
Janssen-Cilag B.V.
Conditions:
Anemia
Blood Loss, Surgical
Eligibility:
All Genders
18+ years
Brief Summary
The purpose of this study is to observe the methods used to manage blood loss in surgical procedures to remove tumors from patients with cancer and to determine if there is a relationship with the nee...
Detailed Description
Considerable blood loss typically accompanies surgical procedures to remove malignant tumors. Blood transfusions, the best method of compensating for blood loss during surgery, have associated medical...
Eligibility Criteria
Inclusion
- Patients with a malignant tumor for which surgery is the first treatment
- Having an expected blood loss of at least 500 ml (100 teaspoons), and not more than 3000 ml (600 teaspoons)
Exclusion
- Patients with a malignant tumor for which surgery is not the first treatment (i.e. have received chemotherapy first)
- Inability to speak, read and write Dutch
Key Trial Info
Start Date :
July 1 2004
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
February 1 2006
Estimated Enrollment :
488 Patients enrolled
Trial Details
Trial ID
NCT00264095
Start Date
July 1 2004
End Date
February 1 2006
Last Update
April 28 2014
Active Locations (11)
Enter a location and click search to find clinical trials sorted by distance.
1
Alkmaar, Netherlands
2
Amersfoort, Netherlands
3
Apeldoorn, Netherlands
4
Deventer, Netherlands